Cannvas MedTech (CSE:MTEC), a leading digital cannabis education and business technology company in the cannabis space, is pleased to announce its online learning platform Cannvas.Me will be featured in an upcoming installment of Canadian Health and Family.

“Presenting our Cannvas.Me platform on this popular health and wellness program is a strong opportunity to share our free and unbiased digital cannabis education resource to a wide swath of Canadians who may be curious about using cannabis as an alternative therapeutic treatment,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “Canadian Health and Family enjoys an engaged following both online and on television, reaching beyond its viewership to contribute to conversations by family physicians and general practitioners throughout Canada, and affecting advocacy groups and resource organizations such as the Chronic Pain Association of Canada. As cannabis becomes a more prevalent part of people’s health care regimen, it’s imperative Canadians know where to turn for accessible and reliable physician-backed cannabis information and education.”


The program makes note of the independent Medical Advisory Board and Educational Advisory Panel who steer content for Cannvas.Me and pays special attention to the platform’s global reach, from its founders’ travels across the world to determine how best to approach cannabis education to the site’s scalability across different countries as cannabis legislation around the world continues to evolve. Additionally, there is also focus on the forthcoming Cannvas.Pet platform, designed to help pet owners explore the use of medical cannabis to help treat their pet’s ailments.

“A crucial aspect of cannabis legalization that has been overlooked since its October inception is access to free and unbiased education around the plant and an opportunity for Canadians to learn for themselves whether or not it can be a beneficial part of their lifestyle,” said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. “We strive to elevate cannabis learning and open the public’s eyes to the myriad health care benefits the plant offers, better contextualizing its place in our culture and delivering evidence-backed education from a team of certified health practitioners and educators.”

About H&F Continuing Education, Inc.
H&F Continuing Education is a leader in health communications and broadcast throughout North America with over 25 years’ experience in launching educational programs empowering consumers regarding their health and lives. For the past 9 years, with Dr. Marla Shapiro as medical contributor to CTV, we have been bringing disease prevention and awareness programs to the Canadian public on CTV, as well as advocacy communities, with up-to-date information delivered by some of the world’s most recognized industry and medical experts. Our Health and Family franchise has created one of the most effective ongoing conversations between patients, families and physicians in many therapeutic areas, in a very personal way.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: www.cannvasmedtech.com; Media Inquiries: media@cannvasmedtech.com; Investor Relations: Renmark Financial Communications Inc., Shushu Feng, sfeng@renmarkfinancial.com, Tel: (416) 644-2020 or (212) 812-7680

Related Links

https://cannvasmedtech.com

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investor Presentation. 

Source: www.newswire.ca

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less